Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion type Assertion NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_head.
- NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion description "[Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_provenance.
- NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion evidence source_evidence_literature NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_provenance.
- NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion SIO_000772 24877854 NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_provenance.
- NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion wasDerivedFrom befree-20150227 NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_provenance.
- NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_assertion wasGeneratedBy ECO_0000203 NP341773.RADvlg0BGi6pCfBhkLYqp7yhXNS3k2BGdcEkJ_H1t7RQU130_provenance.